The Society for Immunotherapy of Cancer, previously known as the International Society for Biological Therapy of Cancer, is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Society for Immunotherapy of Cancer, United States, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
71%
Total
Publications
55
Total Open
Publications
39
Total
Citations
2.1K
Open Access
Percentage
71%
Total
Publications
55
Total Open
Publications
39
Total
Citations
2.1K
Breakdown
Publisher Open
7%
Both
60%
Other Platform Open
4%
Closed
29%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 95%
35
Hybrid 0%
0
No Guarantees 5%
2
Other Platform Open
Domain 86%
30
Institution 20%
7
Other Internet 20%
7
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 30 |
DOI | Other Internet | 7 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |
DANS - Data Archiving and Networked Services | Institution | 3 |
Europe PMC | Domain | 2 |
DASH - Digital Access to Scholarship at Harvard | Institution | 2 |
Université de Lausanne - SERVAL | Institution | 1 |
University of Siena - Use Siena air | Institution | 1 |
University of Padua - Padua Research Archive | Institution | 1 |
University of Michigan - Deep Blue | Institution | 1 |